Searchable abstracts of presentations at key conferences in endocrinology

ea0032p160 | Calcium and Vitamin D metabolism | ECE2013

A case report: hypoparathyroidism, nephrocalcinosis, and replacement therapy

Boysan Serife Nur , Ozgen Zeren , Sahin Tuna

Introduction: There is a risk of hypercalcemia, nephrolithiasis, nephrocalsinosis, and renal failure in the treatment of hypoparathyroidism. We present a case who has an improvement of this complication after changing large doses of vitamin D to physiological doses of 1,25(OH)2D itself.Case report: A 50 years old man was admitted to hospital. He had idiopathic hypoparatyhroidism from the age of 24. He was using oral 1,25(OH)2D 0.25 ...

ea0026p701 | Diabetes complications | ECE2011

Receptor activator of nuclear factor kappa β ligand and osteoprotegerin levels in the patients with diabetic nephropathy

Kuzuguden Cigdem , Guldiken Sibel , Ustundag Sedat , Ozgen Zeren , Demir Muzaffer

Aim: The aim of this study was to investigate the relationship between the clinical and laboratory findings of metabolic bone disease regarding the levels of osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (RANKL) in the patients with diabetic nephropathy.Material and method: This study includes 61 type 2 diabetic patients and age-, sex-matched 20 healthy subjects. Diabetic patients were divided into three groups accordi...